COVID-19 booster discussions have led to a 'communications crisis' and 'nonstop' phone calls

Pfizer-BioNTech vaccine.
(Image credit: RAJESH JANTILAL/AFP via Getty Images)

The back-and-forth on COVID-19 booster shots among the Food and Drug Administration, the Centers for Disease Control and Prevention, and their advisory panels amounts to a "communications crisis," Robert Murphy, the executive director of the Institute for Global Health at Northwestern University Feinberg School of Medicine, told The Washington Post.

Many Americans seem like they aren't sure if they're eligible for a third dose of the Pfizer-BioNTech vaccine (the only one of the three available shots that's received formal discussions on boosters) because of hard-to-follow guidance from public health officials — first, the CDC advisory panel narrowed the FDA panel's initial recommendation, and then CDC Director Rochelle Walensky overruled that, broadening it again.

The situation, though, has led to a deluge of phone calls to healthcare providers at the local level. For instance, a customer service representative for Primary Health clinics in southwestern Idaho told the Post "the calls seem pretty nonstop." David Peterman, Primary Health's chief executive, said in light of the booster confusion "we went from 40,000 phone calls daily to 80,000," prompting him to ask staffers to take extra shifts.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

Jay A. Winsten, the founding director of the Center for Health Communications at the Harvard T.H. Chan School of Public Health, thinks the solution should come from the top. While the FDA and CDC have a lot of experts in the health and science fields, "what's missing from the equation are communication experts," Winsten said, adding that "they need a seat at the table." Read more at The Washington Post.

Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.